ZTS Q4 2025 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$54B

Q4 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.4B+3.0% YoY

Gross Profit

$1.6B68.9% margin

Operating Income

$826M34.6% margin

Net Income

$603M25.3% margin

EPS (Diluted)

$1.37

QoQ Revenue Growth

-0.5%

Cash Flow

Operating Cash Flow

$893M

Free Cash Flow

$732M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$15.5B

Total Liabilities

$12.1B

Stockholders' Equity

$3.3B

Cash & Equivalents

$2.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.4B	$2.3B	+3.0%
Gross Profit	$1.6B	$1.6B	+4.3%
Operating Income	$826M	$765M	+8.0%
Net Income	$603M	$581M	+3.8%

Revenue Segments

Horses

$6.1B89%

Cattle

$415M6%

Swine

$125M2%

Poultry

$117M2%

Fish

$81M1%

Geographic Segments

United States Segment

$1.2B52%

International Segment

$1.1B48%